Augustine Therapeutics is Participating at J.P. Morgan's 41st Annual Health Care Conference in San Francisco

16.12.2022

Our CEO, Sylvain Celanire, will be participating in J.P. Morgan's 41st Annual Health Care Conference from January 9th-11th 2023 in San Francisco.

This premier conference is the largest healthcare investment symposium in the industry which connects global industry leaders, emerging fast-growth companies, innovative technology creators, and investment community members.

Please reach out to us for arranging 1-1 meetings and learn more about our program targeting HDAC6 inhibition for the treatment of #neuromuscular, and neurodegenerative disorders and beyond.

10/02/2023 Event

Augustine Therapeutics' leadership team will be attending 16th European Life Science CEO Forum in Zurich, Switzerland

05/06/2023 Event

Augustine Tx is participating at the 2023 PNS (Peripheral Nerve Society) Annual Meeting at the Bella Center, Copenhagen

28/07/2023 Event

We are proud to sponsor the 2023 Global CMT Research Convention at Royal Sonesta, Boston held on 22nd and 23rd September.

All news articles

A thinline.be | soon production

Wijzig uw cookie voorkeuren

Our CEO, Sylvain Celanire, will be participating in J.P. Morgan's 41st Annual Health Care Conference from January 9th-11th 2023 in San Francisco.

Augustine Therapeutics' leadership team will be attending 16th European Life Science CEO Forum in Zurich, Switzerland

Augustine Tx is participating at the 2023 PNS (Peripheral Nerve Society) Annual Meeting at the Bella Center, Copenhagen

We are proud to sponsor the 2023 Global CMT Research Convention at Royal Sonesta, Boston held on 22nd and 23rd September.